Genetic association and risk scores in a chronic obstructive pulmonary disease meta-analysis of 16,707 subjects

American Journal of Respiratory Cell and Molecular Biology

Volumn 57, Issue 1, 2017, Pages 35-46

  Busch, Robert ^a   Hobbs, Brian D ^a   Zhou, Jin ^b   Castaldi, Peter J ^a   McGeachie, Michael J ^a   Hardin, Megan E ^a   Hawrylkiewicz, Iwona ^c   Sliwinski, Pawel ^c   Yim, Jae Joon ^d   Kim, Woo Jin ^e   Kim, Deog K ^d   Agusti, Alvar ^f   Make, Barry J ^g   Crapo, James D ^g   Calverley, Peter M ^h   Donner, Claudio F ⁱ   Lomas, David A ^j   Wouters, Emiel F ^k   Vestbo, Jorgen ^l   Tal Singer, Ruth ^m   Bakke, Per ⁿ   Gulsvik, Amund ⁿ   Litonjua, Augusto A ^a   Sparrow, David ^a   Pare, Peter D ^o   Levy, Robert D ^o   Rennard, Stephen I ^p   Beaty, Terri H ^q   Hokanson, John ^r   Silverman, Edwin K ^a   Cho, Michael H ^a   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Institute for Tuberculosis and Lung Diseases   (Poland)

^d Seoul National University College of Medicine   (South Korea)

^e Kangwon National University   (South Korea)

^f UNIVERSITY OF BARCELONA   (Spain)

^g DEPARTMENT OF MEDICINE   (United States)

^h UNIVERSITY OF LIVERPOOL   (United Kingdom)

ⁱ Multidisciplinary and Rehabilitation Outpatient Clinic   (Italy)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

^k MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^l UNIVERSITY OF MANCHESTER   (United Kingdom)

^m GLAXOSMITHKLINE   (United States)

ⁿ UNIVERSITY OF BERGEN   (Norway)

^o UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^p UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^q JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^r UNIVERSITY OF COLORADO   (United States)

more..

Author keywords

Chronic obstructive pulmonary disease; Genetic epidemiology; Genetic risk factors; alpha 1 antitrypsin; Genetic risk score

Indexed keywords

ALPHA 1 ANTITRYPSIN; C10ORF11 PROTEIN; CDC123 PROTEIN; CHRNA3 PROTEIN; CHRNA5 PROTEIN; CYCLOPHILIN C; CYTOCHROME P450 2A6; DNER PROTEIN; FAM13A PROTEIN; HHIP PROTEIN; HISTONE DEACETYLASE 4; HLA DQB1 ANTIGEN; HTR4 PROTEIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; IREB2 PROTEIN; LRP1 PROTEIN; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE 15; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; PPP4R4 PROTEIN; PPT2 PROTEIN; PROTEIN; PROTEIN PATCHED 1; RIN3 PROTEIN; SERPINA1 PROTEIN; SPATA9 PROTEIN; STROMELYSIN; THSD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG; ZKSCAN3 PROTEIN;

ADULT; ALLELE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC ASSOCIATION STUDY; GENETIC RISK; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MIDDLE AGED; QUANTITATIVE TRAIT LOCUS; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; AGED; GENETIC PREDISPOSITION; GENETICS; LUNG FUNCTION TEST; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR;

AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK FACTORS;

EID: 85021733485     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2016-0331OC     Document Type: Article

References (58)

1. Kochanek KD, Murphy SL, Xu J. Deaths: final data for 2011. Natl Vital Stat Rep 2015;63:1-120
2. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365
3. Ingebrigtsen T, Thomsen SF, Vestbo J, van der Sluis S, Kyvik KO, Silverman EK, Svartengren M, Backer V. Genetic influences on chronic obstructive pulmonary disease-A twin study. Respir Med 2010;104:1890-1895
4. McCloskey SC, Patel BD, Hinchliffe SJ, Reid ED, Wareham NJ, Lomas DA. Siblings of patients with severe chronic obstructive pulmonary disease have α significant risk of airflow obstruction. Am J Respir Crit Care Med 2001;164:1419-1424
5. Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, Campbell EJ, O'Donnell WJ, Reilly JJ, Ginns L, Mentzer S, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease: risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998;157:1770-1778
6. Burrows B, Knudson RJ, Cline MG, Lebowitz MD. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977;115:195-205
7. Wain LV, Shrine N, Miller S, Jackson VE, Ntalla I, Soler Artigas M, Billington CK, Kheirallah AK, Allen R, Cook JP, et al.; UK Brain Expression Consortium (UKBEC); OxGSK Consortium. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): α genetic association study in UK Biobank. Lancet Respir Med 2015;3:769-781
8. Cho MH, Castaldi PJ, Wan ES, Siedlinski M, Hersh CP, Demeo DL, Himes BE, Sylvia JS, Klanderman BJ, Ziniti JP, et al.; ICGN Investigators; ECLIPSE Investigators; COPDGene Investigators. A genome-wide association study of COPD identifies α susceptibility locus on chromosome 19q13. Hum Mol Genet 2012;21:947-957
9. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh CP, Bakke P, Gulsvik A, et al.; ICGN Investigators. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009;5:e1000421
10. DeMeo DL, Mariani T, Bhattacharya S, Srisuma S, Lange C, Litonjua A, Bueno R, Pillai SG, Lomas DA, Sparrow D, et al. Integration of genomic and genetic approaches implicates IREB2 as a COPD susceptibility gene. Am J Hum Genet 2009;85:493-502
11. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, DeMeo DL, Hunninghake GM, Litonjua AA, Sparrow D, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 2010;42:200-202
12. Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, Klemm A, Flicek P, Manolio T, Hindorff L, et al. The NHGRI GWAS catalog, a curated resource of SNP-trait associations. Nucleic Acids Res 2014; 42:D1001-D1006
13. Zhou JJ, Cho MH, Castaldi PJ, Hersh CP, Silverman EK, Laird NM. Heritability of chronic obstructive pulmonary disease and related phenotypes in smokers. Am J Respir Crit Care Med 2013;188: 941-947
14. Chakravarti A, Clark AG, Mootha VK. Distilling pathophysiology from complex disease genetics. Cell 2013;155:21-26
15. Corvol H, Hodges CA, Drumm ML, Guillot L. Moving beyond genetics: is FAM13A α major biological contributor in lung physiology and chronic lung diseases? J Med Genet 2014;51:646-649
16. Young RP, Hopkins RJ, Hay BA, Whittington CF, Epton MJ, Gamble GD. FAM13A locus in COPD is independently associated with lung cancer-evidence of α molecular genetic link between COPD and lung cancer. Appl Clin Genet 2010;4:1-10
17. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006;38:209-213
18. Cho MH, McDonald ML, Zhou X, Mattheisen M, Castaldi PJ, Hersh CP, Demeo DL, Sylvia JS, Ziniti J, Laird NM, et al.; NETT Genetics, ICGN, ECLIPSE and COPDGene Investigators. Risk loci for chronic obstructive pulmonary disease: α genome-wide association study and meta-analysis. Lancet Respir Med 2014;2:214-225
19. Castaldi PJ, Cho MH, Litonjua AA, Bakke P, Gulsvik A, Lomas DA, Anderson W, Beaty TH, Hokanson JE, Crapo JD, et al.; COPDGene and Eclipse Investigators. The association of genome-wide significant spirometric loci with chronic obstructive pulmonary disease susceptibility. Am J Respir Cell Mol Biol 2011;45:1147-1153
20. Repapi E, Sayers I, Wain LV, Burton PR, Johnson T, Obeidat M, Zhao JH, Ramasamy A, Zhai G, Vitart V, et al.; Wellcome Trust Case Control Consortium; NSHD Respiratory Study Team. Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010;42:36-44
21. Soler Artigas M, Loth DW, Wain LV, Gharib SA, Obeidat M, Tang W, Zhai G, Zhao JH, Smith AV, Huffman JE, et al.; Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 2011;43:1082-1090
22. Hancock DB, Soler Artigas M, Gharib SA, Henry A, Manichaikul A, Ramasamy A, Loth DW, Imboden M, Koch B, McArdle WL, et al. Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function. PLoS Genet 2012;8:e1003098
23. Liu S, Song Y. Building genetic scores to predict risk of complex diseases in humans: is it possible? Diabetes 2010;59:2729-2731
24. Young RP, Hopkins RJ, Hay BA, Gamble GD. Joint effect of singlenucleotide polymorphisms and smoking exposure in chronic obstructive pulmonary disease risk. Am J Respir Crit Care Med 2012; 185:683, author reply 683-684
25. Soler Artigas M, Wain LV, Repapi E, Obeidat M, Sayers I, Burton PR, Johnson T, Zhao JH, Albrecht E, Dominiczak AF, et al.; Medical Research Council National Survey of Health and Development (NSHD) Respiratory Study Team; SpiroMeta Consortium. Effect of five genetic variants associated with lung function on the risk of chronic obstructive lung disease, and their joint effects on lung function. Am J Respir Crit Care Med 2011;184:786-795
26. Zhou X, Baron RM, Hardin M, Cho MH, Zielinski J, Hawrylkiewicz I, Sliwinski P, Hersh CP, Mancini JD, Lu K, et al. Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIP. Hum Mol Genet 2012;21:1325-1335
27. Zhu G, Warren L, Aponte J, Gulsvik A, Bakke P, Anderson WH, Lomas DA, Silverman EK, Pillai SG; International COPD Genetics Network (ICGN) Investigators. The SERPINE2 gene is associated with chronic obstructive pulmonary disease in two large populations. Am J Respir Crit Care Med 2007;176:167-173
28. Patel BD, Coxson HO, Pillai SG, Agustí AG, Calverley PM, Donner CF, Make BJ, Muller NL, Rennard SI, Vestbo J, et al.; International COPD Genetics Network. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178:500-505
29. Silverman EK, Weiss ST, Drazen JM, Chapman HA, Carey V, Campbell EJ, Denish P, Silverman RA, Celedon JC, Reilly JJ, et al. Genderrelated differences in severe, early-onset chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;162: 2152-2158
30. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010;7:32-43
31. Vestbo J, AndersonW, Coxson HO, Crim C, Dawber F, Edwards L, Hagan G, Knobil K, Lomas DA, MacNee W, et al.; ECLIPSE investigators. Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE). Eur Respir J 2008;31:869-873
32. Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A, Weinmann G, Wood DE; National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volumereduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073
33. Bell B, Rose CL, Damon A. The Normative Aging Study: an interdisciplinary and longitudinal study of health and aging. Int J Aging Hum Dev 1972;3:5-17
34. Sørheim IC, Johannessen A, Grydeland TB, Omenaas ER, Gulsvik A, Bakke PS. Case-control studies on risk factors for chronic obstructive pulmonary disease: how does the sampling of the cases and controls affect the results? Clin Respir J 2010;4:89-96
35. Hobbs BD, Parker MM, Chen H, Lao T, Hardin M, Qiao D, Hawrylkiewicz I, Sliwinski P, Yim JJ, Kim WJ, et al.; NETT Genetics Investigators; ECLIPSE Investigators; COPDGene Investigators; International COPD Genetics Network Investigators. Exome array analysis identifies α common variant in IL27 associated with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2016; 194:48-57
36. Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 2015;4:7
37. Chen MH, Yang Q. GWAF: an R package for genome-wide association analyses with family data. Bioinformatics 2010;26:580-581
38. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010;26: 2190-2191
39. Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, Franceschini N, van Durme YM, Chen TH, Barr RG, et al. Metaanalyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010;42:45-52
40. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M. pROC: an open-source package for R and S1 to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77
41. Aulchenko YS, Ripke S, Isaacs A, van Duijn CM. GenABEL: an R library for genome-wide association analysis. Bioinformatics 2007;23: 1294-1296
42. Hobbs BD, Hardin M, Hawrylkiewicz I, Sliwinski P, Yim JJ, Kim WJ, Kim DK, Agusti A, Make BJ, Calverley PM, et al. Coding variant associations with lung function and COPD using an exome array. Presented at the American Thoracic Society 2015 International Conference, Denver, Colorado; 2015
43. GTEx Consortium. Human genomics: the Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 2015;348:648-660
44. Ward LD, Kellis M. HaploReg: α resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2012;40:D930-D934
45. Carrell RW, Jeppsson JO, Laurell CB, Brennan SO, OwenMC, Vaughan L, Boswell DR. Structure and variation of human a1-antitrypsin. Nature 1982;298:329-334
46. Wu Y, Foreman RC. The molecular genetics of a1 antitrypsin deficiency. BioEssays 1991;13:163-169
47. Cho MH, Castaldi PJ, Hersh CP, Hobbs BD, Barr RG, Tal-Singer R, Bakke P, Gulsvik A, JoséEstépar R, Van Beek EJ, et al.; NETT Genetics, ECLIPSE, and COPDGene Investigators. A genome-wide association study of emphysema and airway quantitative imaging phenotypes. Am J Respir Crit Care Med 2015; 192:559-569
48. Sørheim IC, Bakke P, Gulsvik A, Pillai SG, Johannessen A, Gaarder PI, Campbell EJ, Agustí A, Calverley PM, Donner CF, et al. a1-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest 2010;138: 1125-1132
49. Thun GA, Imboden M, Ferrarotti I, Kumar A, Obeidat M, Zorzetto M, Haun M, Curjuric I, Couto Alves A, Jackson VE, et al. Causal and synthetic associations of variants in the SERPINA gene cluster with a1-antitrypsin serum levels. PLoS Genet 2013;9:e1003585
50. Pencina MJ, D'Agostino RB, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of α new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27:157-172; discussion 207-112
51. Hu R, Ouyang Q, Dai A, Tan S, Xiao Z, Tang C. Heat shock protein 27 and cyclophilin A associate with the pathogenesis of COPD. Respirology 2011;16:983-993
52. Nigro P, Pompilio G, Capogrossi MC. Cyclophilin A: α key player for human disease. Cell Death Dis 2013;4:e888
53. Davis CA, Haberland M, Arnold MA, Sutherland LB, McDonald OG, Richardson JA, Childs G, Harris S, Owens GK, Olson EN. PRISM/PRDM6, α transcriptional repressor that promotes the proliferative gene program in smooth muscle cells. Mol Cell Biol 2006;26:2626-2636
54. Jostins L, Barrett JC. Genetic risk prediction in complex disease. Hum Mol Genet 2011;20:R182-R188
55. Talmud PJ, Hingorani AD, Cooper JA, MarmotMG, Brunner EJ, Kumari M, Kivimaki M, Humphries SE. Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study. BMJ 2010;340:b4838
56. Lange P, Celli B, Agustí A, Boje Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 2015;373:111-122
57. Jackson VE, Ntalla I, Sayers I, Morris R, Whincup P, Casas JP, Amuzu A, Choi M, Dale C, Kumari M, et al. Exome-wide analysis of rare coding variation identifies novel associations with COPD and airflow limitation in MOCS3, IFIT3 and SERPINA12. Thorax 2016;71:501-509
58. Soler Artigas M, Wain LV, Miller S, Kheirallah AK, Huffman JE, Ntalla I, Shrine N, Obeidat M, Trochet H, McArdle WL, et al.; UK BiLEVE. Sixteen new lung function signals identified through 1000 Genomes Project reference panel imputation. Nat Commun 2015;6:8658